Bariatric surgery is associated with improvement in kidney outcomes

Slides:



Advertisements
Similar presentations
Volume 82, Issue 12, Pages (December 2012)
Advertisements

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Improved prognosis of diabetic nephropathy in type 1 diabetes
Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.
Volume 93, Issue 6, Pages (June 2018)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Urinary ammonia and long-term outcomes in chronic kidney disease
Volume 58, Issue 1, Pages (July 2000)
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Volume 93, Issue 4, Pages (April 2018)
Volume 92, Issue 1, Pages (July 2017)
Volume 92, Issue 2, Pages (August 2017)
Jason T. Lee, MD, Vinit N. Varu, MD, Kenneth Tran, BS, Ronald L
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Volume 93, Issue 1, Pages (January 2018)
Matei Neagu, PhD, Daniel Coca, PhD, Albert C.M. Ong, DM 
Volume 93, Issue 1, Pages (January 2018)
Volume 80, Issue 1, Pages (July 2011)
Volume 88, Issue 2, Pages (August 2015)
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)  Richard.
Volume 93, Issue 5, Pages (May 2018)
Volume 82, Issue 12, Pages (December 2012)
Volume 78, Issue 8, Pages (October 2010)
Renal function changes after fenestrated endovascular aneurysm repair
Peripheral microvascular parameters in the nephrotic syndrome
Volume 91, Issue 2, Pages (February 2017)
Volume 69, Pages S11-S15 (April 2006)
Volume 92, Issue 1, Pages (July 2017)
Volume 79, Issue 12, Pages (June 2011)
Volume 66, Issue 3, Pages (September 2004)
Volume 93, Issue 1, Pages (January 2018)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian, Yan Yan, Ziyad Al-Aly 
How to interpret the eGFR in patients with small body surface area
Renal dysfunction and the associated decrease in survival after elective endovascular aneurysm repair  Devin S. Zarkowsky, MD, Caitlin W. Hicks, MD, MS,
Steven J. Rosansky, Richard J. Glassock  Kidney International 
Volume 91, Issue 1, Pages (January 2017)
Renal risk scores: Progress and prospects
Volume 79, Issue 9, Pages (May 2011)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
U-shaped effect of eGFR and mortality
Volume 83, Issue 4, Pages (April 2013)
Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease  Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.
Volume 86, Issue 3, Pages (September 2014)
Volume 81, Issue 6, Pages (March 2012)
Volume 85, Issue 3, Pages (March 2014)
Atherosclerotic renovascular disease among hypertensive adults
Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices  Shinichi Fukuhara, MD,
Volume 82, Issue 7, Pages (October 2012)
Proteinuria and hypertensive nephrosclerosis in African Americans
Methods for guideline development
Volume 93, Issue 1, Pages (January 2018)
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
Volume 76, Issue 8, Pages (October 2009)
Volume 61, Issue 1, Pages (January 2002)
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 85, Issue 5, Pages (May 2014)
Volume 77, Issue 12, Pages (June 2010)
Volume 64, Issue 2, Pages (August 2003)
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial 
Volume 60, Issue 1, Pages (July 2001)
Volume 81, Issue 7, Pages (April 2012)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Volume 75, Issue 1, Pages (January 2009)
Friends, social networks, and progressive chronic kidney disease
Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system  Victoria A. Kumar, Margo A. Sidell,
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study  Zhi Yu, Casey M. Rebholz, Eugenia.
Volume 60, Issue 1, Pages (July 2001)
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Bariatric surgery is associated with improvement in kidney outcomes Alex R. Chang, Yuan Chen, Christopher Still, G. Craig Wood, H. Lester Kirchner, Meredith Lewis, Holly Kramer, James E. Hartle, David Carey, Lawrence J. Appel, Morgan E. Grams  Kidney International  Volume 90, Issue 1, Pages 164-171 (July 2016) DOI: 10.1016/j.kint.2016.02.039 Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 1 Trajectories of weight and eGFR in bariatric surgery patients and matched controls. Trajectories of weight and estimated glomerular filtration rate (eGFR) were adjusted for propensity score and baseline weight and eGFR, respectively, in mixed effects models with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan-Meier curves estimating time to kidney outcomes by surgery group and control group. The estimated glomerular filtration rate (eGFR) decline ≥30% outcome was defined as having a follow-up outpatient eGFR ≥30% lower than the baseline eGFR value. ESRD was defined as eGFR <15 ml/min/1.73 m2 or treated ESRD per US Renal Data System registry. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 3 Trajectories of eGFR stratified by baseline eGFR. Trajectories of estimated glomerular filtration rate (eGFR) for patients with baseline eGFR ≥90 and <90 were examined using mixed effects models adjusted for propensity score and baseline eGFR, with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S1 Distribution of propensity scores in matched surgery and control patients. Controls were selected by matching patients without bariatric surgery with those with bariatric surgery using caliper sizes one-half the SD of the propensity scores. Matched controls were successfully identified for 985 of 1394 bariatric surgery patients. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S2 Trajectories of systolic blood pressure. Trajectories of systolic blood pressure were examined, using mixed-effects models adjusted for propensity score, with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S3 Prevalence of ICD-9 diagnosis of hypertension over time. Prevalence of hypertension over time was examined, using mixed-effects models adjusted for propensity score, with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S4 Prevalence of ICD-9 diagnosis of diabetes over time. Prevalence of diabetes over time was examined, using mixed-effects models adjusted for propensity score, with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S5 Kaplan-Meier curves estimating time to eGFR decline ≥30% requiring 2 qualifying eGFR values. Outcome defined as having 2 follow-up outpatient eGFRs of ≥30% lower than the baseline eGFR value. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S6 Trajectories of eGFR stratified by hypertension status. Trajectories of eGFR for patients stratified by baseline hypertension were examined, using mixed-effects models adjusted for propensity score and baseline eGFR, with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. The upper red and blue lines represent individuals without hypertension, and the lower red and blue lines represent individuals with hypertension. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure S7 Trajectories of eGFR stratified by diabetes status. Trajectories of eGFR for patients stratified by baseline diabetes were examined, using mixed effects models adjusted for propensity score and baseline eGFR, with random intercept and slopes for each individual, allowing unstructured correlation between the random effects. The upper red and blue lines represent individuals without diabetes, and the lower red and blue lines represent individuals with diabetes. Time was modeled using restricted cubic splines with 5 knots at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. Shaded areas represent 95% confidence interval bounds. Kidney International 2016 90, 164-171DOI: (10.1016/j.kint.2016.02.039) Copyright © 2016 International Society of Nephrology Terms and Conditions